EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN MACULAR OEDEMA IN POSTERIOR SEGMENT CONDITIONS

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 66

Abstract

BACKGROUND Macular oedema is a major cause for visual impairment in many posterior segment conditions like diabetic macular oedema, branch retinal vein occlusions, posterior uveitis and pseudophakic CMO. The failure of laser photocoagulation in improving visual acuity and reducing macular oedema has prompted interest in other treatment methods. The aim of the study is to evaluate the efficacy and safety of an intravitreal injection of triamcinolone acetonide for patients presenting with macular oedema. MATERIALS AND METHODS Forty eyes of 40 patients with ME from BRVO and DR were enrolled in the study. All patients underwent complete ophthalmic examinations including BCVA and OCT measurements of CMT. All patients received intravitreal injection of 4 mg triamcinolone acetonide. The change in BCVA and reduction in CMT were assessed. Intraocular pressure spikes and other complications were noted. Statistical analysis was carried out using SPS software. RESULTS The mean age of included patients (19 males, 21 females) was 57.5 ± 8 years (41-70 years). The mean follow-up period was 4 months. The mean baseline BCVA of patients in Logarithm of Minimal Angle of Resolution (LogMAR) before intravitreal triamcinolone injection was 0.966 ± 0.37. After treatment, it was 0.358 ± 0.33 at 1 month, 0.397 ± 0.33 at fourth month and the differences were statistically significant when compared with baseline values (P<0.001). The mean CMT at baseline was 466.98 ± 126.32 µm and it significantly decreased to 272.10 ± 56.03 µm at 1 month, 309.38 ± 134.55 at 3 month (P<0.001). Postoperative complications noted included acute traumatic cataract, raised IOP, progression of cataract and sterile endophthalmitis. CONCLUSION Intravitreal injection of triamcinolone acetonide is effective in reducing foveal thickness and improving visual acuity in the short term. Further studies are needed to evaluate the long-term efficacy and safety of this treatment.

Authors and Affiliations

Viswanath Bannikuppe Narasimhaiah, Rita Mary Tomy, Shasidhar Swamy, Shruti Prakash Naik

Keywords

Related Articles

ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ORGANISMS CAUSING SURGICAL SITE INFECTIONS (SSI)

BACKGROUND CDC defines surgical site infection as ‘Infections related to operative procedure that occurs at or near surgical incision within 30 days of operative procedure or within one year if the implant is left in sit...

PROSPECTIVE NON-RANDOMISED OBSERVATIONAL CASE STUDY DIABETIC MACULOPATHY

BACKGROUND The epidemiological study of diabetic maculopathy in Indian population for the period of three years duration and study the treatment outcome following laser photocoagulation for various type of diabetic macul...

A RETROSPECTIVE ANALYTICAL STUDY OF PERMANENT VISUAL DISABILITY IN NORTHWEST TAMILNADU

BACKGROUND Impairment in vision is a worldwide problem of socio-economic significance. This study was carried out with objective of analysing various causes of permanent visual disability in North West rural Tamilnadu, I...

PERIANAL DISEASE AS INITIAL MANIFESTATION OF CROHN’S DISEASE

BACKGROUND Crohn’s disease is a chronic inflammatory disease, which involves almost all parts of body. Perianal manifestations maybe the initial presentation in these patients, but usually includes other systemic manifes...

BIOMETRY OF MANDIBLE

BACKGROUND The purpose of study of biometry of mandible is to evaluate the sex of the individual by statistically significant various parameters of the mandible and also a few selected landmark points on the mandible. MA...

Download PDF file
  • EP ID EP267451
  • DOI 10.18410/jebmh/2017/788
  • Views 67
  • Downloads 0

How To Cite

Viswanath Bannikuppe Narasimhaiah, Rita Mary Tomy, Shasidhar Swamy, Shruti Prakash Naik (2017). EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN MACULAR OEDEMA IN POSTERIOR SEGMENT CONDITIONS. Journal of Evidence Based Medicine and Healthcare, 4(66), 3942-3947. https://www.europub.co.uk/articles/-A-267451